Renal denervation for hypertension

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Neuroscience

Background:

• Systemic hypertension poses a significant health burden, linked to severe cardiac and cerebral events.
• Current antihypertensive therapies, while effective, frequently result in suboptimal blood pressure control and adverse drug effects, impacting patient compliance.
• The sympathetic nervous system (SNS) plays a crucial role in hypertension pathogenesis, with recent focus on the renal SNS.

Purpose of the Study:

• To review the anatomy and physiology of the renal sympathetic nervous system (SNS).
• To explore the rationale for therapeutic manipulation of the SNS in hypertension.
• To summarize the outcomes of renal sympathetic denervation for treating resistant hypertension.

Main Methods:

• Literature review focusing on renal sympathetic nervous system (SNS) anatomy, physiology, and its role in hypertension.
• Analysis of studies investigating the effects of interrupting the renal SNS in patients with resistant hypertension.
• Synthesis of data on therapeutic renal sympathetic denervation outcomes.

Main Results:

• The renal SNS is implicated in the development and maintenance of hypertension.
• Interruption of the renal SNS has demonstrated promising results in patients with resistant hypertension.
• Therapeutic renal sympathetic denervation presents a viable alternative treatment strategy.

Conclusions:

• The renal sympathetic nervous system is a key target for managing resistant hypertension.
• Renal sympathetic denervation offers a potentially effective treatment option for patients with suboptimal blood pressure control.
• Further research into SNS modulation may lead to improved hypertension management strategies.